INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 254 filers reported holding INSMED INC in Q3 2023. The put-call ratio across all filers is 6.19 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $417,711 | -93.5% | 16,543 | -93.4% | 0.00% | -93.3% |
| Q2 2019 | $6,379,000 | -35.1% | 249,177 | -26.3% | 0.02% | -37.5% |
| Q1 2019 | $9,825,000 | +42617.4% | 337,970 | +33164.8% | 0.02% | – |
| Q1 2018 | $23,000 | -98.3% | 1,016 | -97.7% | 0.00% | -100.0% |
| Q4 2017 | $1,390,000 | +183.1% | 44,565 | +183.1% | 0.00% | +300.0% |
| Q3 2017 | $491,000 | +91.1% | 15,741 | +7.4% | 0.00% | 0.0% |
| Q1 2017 | $257,000 | – | 14,655 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 5,889,491 | $148,709,648 | 14.07% |
| Deep Track Capital, LP | 6,000,000 | $151,500,000 | 5.85% |
| Octagon Capital Advisors LP | 1,284,000 | $32,421,000 | 4.98% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3,446,334 | $87,019,934 | 4.70% |
| MPM BioImpact LLC | 527,458 | $13,318,315 | 3.56% |
| Novo Holdings A/S | 1,339,304 | $33,817,426 | 2.50% |
| Bleichroeder LP | 325,000 | $8,206,250 | 2.02% |
| GREAT POINT PARTNERS LLC | 394,872 | $9,970,518 | 1.82% |
| Endurant Capital Management LP | 79,471 | $2,006,643 | 1.80% |
| SECTORAL ASSET MANAGEMENT INC | 347,392 | $8,771,648 | 1.71% |